Sequencer Products
Technologies
Applications
Online Resources
Data Bulletins
Service & Support
Introduction
Newsroom
Doing Business With Us
Creative Club
MGI Statement
MGI and its affiliates today announce that they have settled all outstanding litigation in the United States with Illumina. Under the terms of the parties' settlement agreement, each party will dro...
More2022-07-15
MGI
To Develop and Promote Advanced Life Science Tools for Future Healthcare
StatementMGI is pleased that the jury verdict in the United States District Court for the District of Delaware supported all our claims, including: 1. Illumina willfully infringed U.S. Patent Nos. 9,222,132 a...More2022-05-07
StatementMGI is pleased that the Court in the Northern District of California denied Illumina's request to overturn the jury's decision invalidating the '444 patent. The 444 patent was not set to expire until ...More2022-03-29
StatementWe are pleased to see that the jury invalidated the claim of United States Patent No. 7,541,444 asserted by Illumina in the trial in the Northern District of California. This patent contained the broa...More2021-12-01
MGI StatementIn response to the interim ruling by the Hong Kong High Court on 25 February 2021 regarding Illumina’s patent lawsuit against MGI, MGI makes the following statement: MGI welcomes the court’s decisi...More2021-02-25
MGI StatementIn response to the rulings of the Patents Court within the High Court of Justice for England & Wales on 18 February 2021, MGI makes the following statement: We welcome the Court’s decision to give u...More2021-02-20
